Bioimplant with evanescent coating film
US-11278642-B2 · Mar 22, 2022 · US
US12226550B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12226550-B2 |
| Application number | US-202218086506-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 21, 2022 |
| Priority date | Feb 3, 2012 |
| Publication date | Feb 18, 2025 |
| Grant date | Feb 18, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a bioimplant which is capable to inhibit the biofilm formation over a long period of time after an operation. The bioimplant of the present invention comprises a base material of metal, ceramic, or plastic and a thermal spraying film of a calcium phosphate-based material formed at least partially thereon and the silver concentration in the thermal-spray film is 0.05 wt % to 3.00 wt %.
Opening claim text (preview).
What is claimed is: 1. A method of manufacturing a bioimplant, comprising: providing a base material of the bioimplant; forming a coating comprising a calcium phosphate-based material and a silver material on at least a part of a surface of the base material; after forming the coating, heating the coating at a predetermined temperature under a predetermined pressure to form oxyapatite in the coating; and immersing the coating in purified water to convert oxyapatite present in the coating to hydroxyapatite, wherein the immersing results in fine crystals of the hydroxyapatite being formed on a surface of the coating, wherein a size of the fine crystals of hydroxyapatite is in a range of 0.01 μm to 2.00 μm in length, thickness or width, and wherein a temperature of the purified water is in a range of 60 to 100 degrees Celsius. 2. The method according to claim 1 , wherein said calcium phosphate-based material is a compound or a mixture of two or more compounds selected from the group consisting of hydroxyapatite, alpha-tricalcium phosphate, beta-tricalcium phosphate, and tetracalcium phosphate. 3. The method according to claim 1 , wherein the base material comprises a metal. 4. The method according to claim 1 , wherein the base material comprises ceramic. 5. The method according to claim 1 , wherein the base material comprises a plastic. 6. The method according to claim 1 , wherein: the heating is performed at a temperature range of 550 to 850 degrees Celsius for a period of time in the range of 1 to 5 hours; and the immersing is performed for a period of time in the range of 10 to 60 μminutes. 7. The method according to claim 1 , wherein the resulting coating comprises a silver concentration in the range of 0.05 wt % to 3.00 wt %. 8. The method according to claim 1 , wherein the forming the coating is performed by applying a thermal sprayed film comprising a calcium phosphate-based material and a silver material.
Silver, e.g. silver sulfadiazine · CPC title
Biocides, antimicrobial agents, antiseptic agents · CPC title
Methods for coating medical devices · CPC title
Phosphorus-containing materials, e.g. apatite · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.